Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aromatase Inhibitors Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05264649
What this trial is testing

Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer

Who this might be right for
Arthralgia
Show Chwan Memorial Hospital 72
Not applicableStudy completedNCT01050634
What this trial is testing

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

Who this might be right for
Post Menopausal Women With Early Breast Cancer
Pfizer 980
Testing effectiveness (Phase 2)Active Not RecruitingNCT02738866
What this trial is testing

Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor

Who this might be right for
Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Large-scale testing (Phase 3)Study completedNCT00859703
What this trial is testing

Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer

Who this might be right for
Breast CancerMenopauseOsteopenia
Hospices Civils de Lyon 20
Not applicableStudy completedNCT02118636
What this trial is testing

Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms

Who this might be right for
Breast CancerArthralgia
Lynn Henry 75
Not applicableUnknownNCT05628077
What this trial is testing

Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors

Who this might be right for
Breast CancerAromatase InhibitorsEndocrine Therapy+4 more
Peking University People's Hospital 1,200
Not applicableNot Yet RecruitingNCT07409948
What this trial is testing

Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal Symptoms

Who this might be right for
Breast NeoplasmsMusculoskeletal PainArthralgia+3 more
Addis Ababa University 88
Large-scale testing (Phase 3)Active Not RecruitingNCT02246621
What this trial is testing

Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 493
Not applicableStudy completedNCT02753686
What this trial is testing

Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy

Who this might be right for
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
Novartis Pharmaceuticals 440
Not applicableUnknownNCT04619485
What this trial is testing

Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser Therapy

Who this might be right for
Breast CancerGenitourinary Syndrome of Menopause
Hospital Clinic of Barcelona 84
Testing effectiveness (Phase 2)Study completedNCT02866955
What this trial is testing

Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.

Who this might be right for
Breast Cancer
Institut de Cancérologie de Lorraine 100
Testing effectiveness (Phase 2)Looking for participantsNCT07810088
What this trial is testing

Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer

Who this might be right for
HR+ / HER2- Advanced Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)Looking for participantsNCT01530373
What this trial is testing

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

Who this might be right for
Hot FlashesBreast Cancer
University of Arkansas 110
Not applicableLooking for participantsNCT06642948
What this trial is testing

AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial

Who this might be right for
Musculoskeletal SymptomsBreast CancerEndocrine Therapy+1 more
Fudan University 80
Not applicableStudy completedNCT01384838
What this trial is testing

Exercise Training in Postmenopausal Patients With Breast Cancer

Who this might be right for
Physical Activity
Arbeitsgemeinschaft medikamentoese Tumortherapie 80
Not applicableLooking for participantsNCT05590949
What this trial is testing

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 100
Post-approval studies (Phase 4)Ended earlyNCT03220178
What this trial is testing

Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy

Who this might be right for
Breast Neoplasm
Palleos Healthcare GmbH 532
Early research (Phase 1)Ended earlyNCT03822715
What this trial is testing

NEOBREADS: Neoadjuvant Breast Diet Study

Who this might be right for
Breast Cancer
Monica Mita 2
Testing effectiveness (Phase 2)Study completedNCT02203331
What this trial is testing

Bay98-7196, Dose Finding / POC Study

Who this might be right for
Endometriosis
Bayer 319
Testing effectiveness (Phase 2)Active Not RecruitingNCT01984138
What this trial is testing

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Who this might be right for
Estrogen Receptor Positive Breast CancerBreast Cancer
Polly A. Niravath, MD 33
Next Page